Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06262594
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2023-12-21
Brief Title:
Lemborexant Treatment of Insomnia Linked to Epilepsy
Sponsor:
University of Manitoba
Organization:
University of Manitoba
Study Overview
Official Title:
Lemborexant Treatment of Insomnia Linked to Epilepsy
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LÉTOILE
Brief Summary:
The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None